Metformin 500 mg Prolonged Release Tablets
Showing 1 - 25 of >10,000
Pharmacokinetics Trial in Prague (Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine), Glucophage® XR 500 mg
Completed
- Pharmacokinetics
- Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine)
- Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 17, 2021
Pharmacokinetics Trial in Prague (Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine), Glucophage® XR 500 mg
Completed
- Pharmacokinetics
- Metformin, prolonged-release tablets 500 mg (JSC Farmak, Ukraine)
- Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 17, 2021
Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg
Completed
- Pharmacokinetics
- Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
- Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 9, 2021
Preeclampsia Trial in Sweden (Metformin ER, Placebo)
Not yet recruiting
- Preeclampsia
- Metformin ER
- Placebo
-
Falun, Sweden
- +5 more
Sep 10, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Drug Use Trial in Jakarta Pusat (Metformin Hydrochloride 500 MG)
Completed
- Drug Use
- Metformin Hydrochloride 500 MG
-
Jakarta Pusat, DKI Jakarta, IndonesiaPT Pharma Metric Labs
Feb 21, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg
Completed
- Pharmacokinetics
- Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
- Glucophage® XR 1000 mg Prolonged Release Tablets
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 17, 2021
Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR
Completed
- Healthy
- Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
- +2 more
-
Cairo, EgyptGenuine Research Center GRC
Mar 2, 2023
Knee Osteoarthritis, Metformin Trial in Dhaka (Metformin 500 Mg extended release Oral Tablet, Placebo oral tablet)
Recruiting
- Knee Osteoarthritis
- Metformin
- Metformin 500 Mg extended release Oral Tablet
- Placebo oral tablet
-
Dhaka, BangladeshBangabandhu Sheikh Mujib Medical University
Nov 13, 2023
Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)
Completed
- Healthy
- Glucophage® XR Test
- Glucophage® XR Reference
-
Daejeon, Korea, Republic ofClinical Trials Center, Chungnam National University Hospital
Mar 30, 2022
Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)
Recruiting
- Healthy
- Test Glucophage® XR
- Reference Glucophage® XR
-
Darmstadt, GermanyResearch Site
Aug 10, 2022
Epilepsy, Lamotrigine, Sodium Valproate Adverse Reaction Trial (Sodium Valproate 500 Mg Prolonged-Release Oral Tablet,
Not yet recruiting
- Epilepsy
- +2 more
- Sodium Valproate 500 Mg Prolonged-Release Oral Tablet
- +2 more
- (no location specified)
May 20, 2023
Healthy Trial in Arzo (Trazodone HCl - new polymer, Trazodone HCl - Contramid®)
Completed
- Healthy
- Trazodone HCl - new polymer
- Trazodone HCl - Contramid®
-
Arzo, SwitzerlandCROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone:
Nov 15, 2021
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Los Angeles (Metformin 500 Mg Oral
Recruiting
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Metformin 500 Mg Oral Tablet, up to 4 tablets a day
- Placebo oral tablet identical to metformin, up to 4 tablets a day
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
May 2, 2022
Lower Urinary Tract Symptoms, Voiding Disorders, Pain Trial in Split (Tadalafil 5mg, Tamsulosin Hydrochloride 400 Microgram
Enrolling by invitation
- Lower Urinary Tract Symptoms
- +3 more
- Tadalafil 5mg
- +2 more
-
Split, Splitsko-dalmatinska, CroatiaUniversity hospital of Splity
Sep 11, 2022
Glucocorticoid Effect Trial in Basel (Metformin 500 mg Oral Tablets + Prednisone 20mg Tablets, Placebo 500 mg Tablets +
Completed
- Glucocorticoid Effect
- Metformin 500 mg Oral Tablets + Prednisone 20mg Tablets
- Placebo 500 mg Tablets + Prednisone 20mg Tablets
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel
Sep 22, 2021
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Empagliflozin, Metformin)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide
- +2 more
-
Toluca Lake, California
- +101 more
Oct 9, 2023
Type 2 Diabetes Trial in Nakhon Pathom (Gemigliptin tartrate sesquihydrate and metformin, gemigliptin 50 mg and metformin HCl
Completed
- Type 2 Diabetes
- Gemigliptin tartrate sesquihydrate and metformin
- gemigliptin 50 mg and metformin hydrochloride 1000 mg prolonged release
-
Nakhon Pathom, ThailandInternational Bio Service Co., Ltd.
Feb 4, 2021
Polycystic Ovary Syndrome (PCOS) Trial in Al Madinah (Metformin Versus a combination of Metformin and Thymoquinone (TQ))
Completed
- Polycystic Ovary Syndrome (PCOS)
- Metformin Versus a combination of Metformin and Thymoquinone (TQ)
-
Al Madīnah, Madinah, Saudi ArabiaSaudi German Hospital
Apr 17, 2021
Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))
Not yet recruiting
- Thyroid Cancer
- metformin
- Radioactive iodine (I-131)
-
Bialystok, PolandDepartment of Endocrinology, Diabetology and Internal Medicine,
Jul 26, 2022
Polycystic Ovary Syndrome Trial in Al Qadisiyah (Metformin Hydrochloride 500 MG, Cabergoline 0.5 MG, Metformin Hydrochloride 500
Completed
- Polycystic Ovary Syndrome
- Metformin Hydrochloride 500 MG
- +2 more
-
Al Qādisīyah, Al-Qādisiyyah Governorate, IraqMaternity and Pediatric Teaching Hospital
Jul 31, 2023
Multiple Sclerosis Trial in Cambridge (Metformin and clemastine in combination, Placebo)
Recruiting
- Multiple Sclerosis
- Metformin and clemastine in combination
- Placebo
-
Cambridge, United KingdomAddenbrooke's Hospital
Jun 14, 2022